Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series.
| Autor: | Aguilar AC; Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Frange C; Departamento de Neurologia e Neurocirurgia, UNIFESP, São Paulo, SP, Brazil., Pimentel Filho LH; Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Reis MJ; Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Tufik S; Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Coelho FMS; Departamento de Psicobiologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.; Departamento de Neurologia e Neurocirurgia, UNIFESP, São Paulo, SP, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) [Braz J Psychiatry] 2020; Vol. 42 (3), pp. 314-316. Date of Electronic Publication: 2019 Dec 20. |
| DOI: | 10.1590/1516-4446-2019-0544 |
| Abstrakt: | Objective: To report the successful use of lisdexamfetamine in the management of narcolepsy. Methods: Five narcoleptic patients received lisdexamfetamine, at different dosages and for different periods, for management of excessive daytime sleepiness and weight control. Results: All patients experienced improvement of excessive daytime sleepiness and lost weight without side effects. Conclusion: Lisdexamfetamine appears promising for the treatment of two of the most common symptoms of narcolepsy: excessive daytime sleepiness and weight gain. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|